Kennedy Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.2M | Sell |
87,163
-11,991
| -12% | -$2.23M | 0.39% | 65 |
|
|
2025
Q1 | $20.8M | Sell |
99,154
-8,984
| -8% | -$1.88M | 0.5% | 36 |
|
|
2024
Q4 | $19.2M | Buy |
108,138
+12,675
| +13% | +$2.25M | 0.43% | 38 |
|
|
2024
Q3 | $18.9M | Buy |
95,463
+14,509
| +18% | +$2.87M | 0.42% | 42 |
|
|
2024
Q2 | $13.9M | Buy |
80,954
+18,448
| +30% | +$3.16M | 0.3% | 91 |
|
|
2024
Q1 | $11.4M | Buy |
62,506
+61,053
| +4,202% | +$11.1M | 0.23% | 142 |
|
|
2023
Q4 | $225K | Buy |
1,453
+10
| +0.7% | +$1.55K | ﹤0.01% | 671 |
|
|
2023
Q3 | $215K | Buy |
+1,443
| New | +$215K | 0.01% | 652 |
|
|
2023
Q2 | – | Sell |
-1,343
| Closed | -$214K | – | 666 |
|
|
2023
Q1 | $214K | Buy |
1,343
+8
| +0.6% | +$1.28K | 0.01% | 601 |
|
|
2022
Q4 | $216K | Buy |
+1,335
| New | +$216K | 0.01% | 594 |
|
|
2022
Q3 | – | Sell |
-1,664
| Closed | -$255K | – | 606 |
|
|
2022
Q2 | $255K | Hold |
1,664
| – | – | 0.01% | 577 |
|
|
2022
Q1 | $270K | Hold |
1,664
| – | – | 0.01% | 577 |
|
|
2021
Q4 | $225K | Buy |
+1,664
| New | +$225K | ﹤0.01% | 601 |
|